Literature DB >> 7695006

Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.

F Fogt1, A O Vortmeyer, S R Tahan.   

Abstract

A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation--AgNOR production and Ki-67 immunoreactivity--were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups). Ki-67 immunoreactivity averaged < 1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695006     DOI: 10.1097/00000372-199502000-00003

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.

Authors:  C Piérard-Franchimont; J E Arrese; A F Nikkels; W al-Saleh; P Delvenne; G E Piérard
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

2.  Versican is differentially expressed in human melanoma and may play a role in tumor development.

Authors:  Malika Touab; Juan Villena; Carlos Barranco; Montserrat Arumí-Uría; Anna Bassols
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

3.  MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia.

Authors:  I Chowers; N Livni; A Solomon; G Zajicek; J Frucht-Pery; R Folberg; J Pe'er
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.